Integrated depression management: A proposed trial of a new model of care in a low vision rehabilitation setting

Ophthalmic Epidemiology

Volumn 20, Issue 5, 2013, Pages 321-329

  Rees, Gwyneth ^a   Mellor, David ^b   Holloway, Edith E ^a   Sturrock, Bonnie A ^a   Hegel, Mark T ^c   Casten, Robin ^d   Xie, Jing ^a   Finkelstein, Eric ^e   Lamoureux, Ecosse ^a   Keeffe, Jill E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Depression; Low vision rehabilitation; Problem solving therapy; Visual impairment

Indexed keywords

ADJUSTMENT; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; ETHICS; FOLLOW UP; HEALTH CARE; HEALTH CARE DELIVERY; HUMAN; INTERVENTION STUDY; LOW VISION; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBLEM SOLVING; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; TELEPHONE; VISUAL IMPAIRMENT;

ADAPTATION, PSYCHOLOGICAL; DELIVERY OF HEALTH CARE, INTEGRATED; DEPRESSIVE DISORDER; HUMANS; MODELS, ORGANIZATIONAL; QUALITY OF LIFE; REFERRAL AND CONSULTATION; VISION, LOW; VISUALLY IMPAIRED PERSONS;

EID: 84885017880     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2013.787102     Document Type: Article

References (50)

1. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002;120(8):1041-1044
2. Rovner BW, Ganguli M. Depression and disability associated with impaired vision: The MoVies Project. J Am Geriatr Soc 1998;46(5):617-619
3. Rovner BW, Casten RJ, Hegel MT, et al. Minimal depression and vision function in age-related macular degeneration. Ophthalmology 2006;113(10):1743- 1747
4. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: A systematic review of prospective studies. Acta Psychiatr Scand 2004; 109(5):325-331
5. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: Risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord 2004; 79(1-3):71-79
6. Rees G, Tee HW, Marella M, et al. Vision-specific distress and depressive symptoms in people with vision impairment. Invest Ophthalmol Visual Sci 2010;51(6):2891-2896
7. Nyman SR, Gosney MA, Victor CR. Emotional well-being in people with sight loss. Br J Vis Impair 2010;28(3):175-203
8. Rees G, Hassell JB, Keeffe J, et al. Psychological outcomes following interventions for people with low vision: A systematic review. Expert Rev Ophthalmol 2010;5(3):385-403
9. Lamoureux EL, Pallant JF, Pesudovs K, et al. The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Visual Sci 2007;48(4):1476-1482
10. Rees G, Fenwick E, Keeffe J, et al. Managing depression in patients with vision impairment: A descriptive study of practitioners' beliefs and confidence. Australas J Ageing 2011;30(3):130-135
11. Rees G, Fenwick EK, Keeffe JE, et al. Detection of depression in patients with low vision. Optom Vis Sci 2009;86:1328-1336
12. National Institute for Clinical Excellence (NICE). Depression in adults with a chronic physical health problem. Treatment and management. London: NICE, 2009
13. Dreer LE, Elliott TR, Fletcher DC, et al. Social problemsolving abilities and psychological adjustment of persons in low vision rehabilitation. Rehabil Psychol 2005;50(3): 232-238
14. Garnefski N, Kraaij V, De Graaf M, et al. Psychological intervention targets for people with visual impairments: The importance of cognitive coping and goal adjustment. Disabil Rehabil 2010;32(2):142-147
15. Rovner BW, Casten RJ. Activity loss and depression in agerelated macular degeneration. Am J Geriatr Psychiatry 2002; 10(3):305-310
16. Allen SM, Shah AC, Nezu AM, et al. A problem-solving approach to stress reduction among younger women with breast carcinoma - A randomized controlled trial. Cancer 2002;94(12):3089-3100
17. Malouff JM, Thorsteinsson EB, Schutte NS. The efficacy of problem solving therapy in reducing mental and physical health problems: A meta-analysis. Clin Psychol Rev 2007; 27(1):46-57
18. Bell AC, D'Zurilla TJ. Problem-solving therapy for depression: A meta-analysis. Clin Psychol Rev 2009;29(4): 348-353
19. Arean P, Hegel M, Vannoy S, et al. Effectiveness of problem-solving therapy for older, primary care patients with depression: Results from the IMPACT Project. The Gerontologist 2008;48(3):311-23
20. Mynors-Wallis LM, Gath DH, Lloydthomas AR, et al. Randomized controlled trial comparing problem-solving treatment with amitriptyline and placebo for major depression in primary-care. BMJ 1995;310(6977):441-445
21. Rovner BW, Casten RJ, Hegel MT, et al. Preventing depression in age-related macular degeneration. Arch Gen Psych 2007;64(8):886-892
22. Hegel MT, Dietrich AJ, Seville JL, et al. Training residents in problem-solving treatment of depression: A pilot feasibility and impact study. Fam Med 2004;36(3):204-208
23. Kroenke K, Spitzer R, Williams JBW. The Patient Health Questionnaire-2: Validity of a two-item depression screener. Med Care 2003;41(11):1284-1292
24. Holloway EE, Sturrock BA, Lamoureux EL, et al. Screening for depression in adults with low vision: Acceptability and treatment preferences. In preparation 2013
25. Kroenke K, Spitzer RL, Williams JB. The PHQ-9. J Gen Intern Med 2001;16(9):606-613
26. Spitzer R, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. J Am Med Assoc 1999;282(18):1737-1744
27. Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry 1999;14(11):936-940
28. Hegel MT, Arean PA. Problem-solving treatment for primary care (PST-PC). A treatment manual for depression. University of California at San Francisco: Dartmouth Medical School, 2003
29. Hegel MT, Barrett JE, Cornell JE, et al. Predictors of response to problem-solving treatment of depression in primary care. Behav Ther 2002;33(4):511-527
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSMIV-TR). Washington, DC: American Psychiatric Association, 2000
31. Pinto-Meza A, Serrano-Blanco A, Peñarrubia MT, et al. Assessing depression in primary care with the PHQ-9: Can it be carried out over the telephone? J Gen Intern Med 2005; 20(8):738-742
32. Nease DE, Maloin JM. Depression screening: A practical strategy. J Fam Pract 2003;52(2):118-124
33. Lamoureux EL, Wen H, Konrad P, et al. Can clinicians use the PHQ-9 to assess depression in people with low vision. Optom Vis Sci 2009;86(2):139-145
34. Misajon R, Hawthorne G, Richardson J, et al. Vision and quality of life: The development of a utility measure. Invest Ophthalmol Vis Sci 2005;46(11):4007-4015
35. Richardson J, Iezzi A, Peacock S, et al. Utility weights for the vision-related assessment of quality of life (AQoL)-7D instrument. Ophthalmic Epidemiol 2012;19(3):173-182
36. Chesney M. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol 2006;11:421-437
37. Manos R, Kanter J, Luo W. The behavioral activation for depression scale-short form: Development and validation. Behav Ther 2011;42:726-739
38. Evers A. Beyond unfavorable thinking: The illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 2001;69(6):1026-1036
39. Horowitz A, Reinhardt JP, Kennedy GJ. Major and subthreshold depression among older adults seeking vision rehabilitation services. Am J Geriatr Psychiatry 2005; 13(3):180-187
40. McMillan D, Gilbody S, Richards D. Defining successful treatment outcome in depression using the PHQ-9: A comparison of methods. J Affect Disord 2010;127:122-129
41. Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004;42(12):1194-1201
42. Finkelstein EA, Will JC, Palombo R. Cost-effectiveness of a cardiovascular disease risk reduction program aimed at financially vulnerable women: The Massachusetts WISEWOMAN Project. J Women's Health Gender-Based Med 2002;11(6):519-526
43. Finkelstein EA, Troped PJ, Will JC, et al. Cost-Effectiveness of WISEWOMAN, a program aimed at reducing heart disease risk among low-income women. J Women's Health 2006;15(4):379-389
44. Peacock S, Misajon R, Iezzi A, et al. Vision and quality of life: Development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol 2008;15(4):218-223
45. Gold MR, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996
46. Koder DA, Helmes E. The current status of clinical geropsychology in Australia: A survey of practising psychologists. Aust Psychol 2008;43(1):22-26
47. Alexander C, Fraser J. General practitioners' management of patients with mental health conditions: The views of general practitioners working in rural northwestern New South Wales. Aust J Rural Health 2008; 16(6):363-369
48. Bambling M, Kavanagh D, Lewis G, et al. Challenges faced by general practitioners and allied mental health services in providing mental health services in rural Queensland. Aust J Rural Health 2007;15(2):126-130
49. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: A review of the epidemiology, risk and treatment evidence. Med J Aust 2009; 190(7):S54-S60
50. Kessler R, Glasgow RE. A proposal to speed translation of healthcare research into practice. Am J Prevent Med 2011; 40(6):337-644